Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials How To Prevent Failure in Rare Disease Trials? Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Operationalizing Precision Medicine in Rare Disease Trials
Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials How To Prevent Failure in Rare Disease Trials? Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Operationalizing Precision Medicine in Rare Disease Trials
